G6PD and Plasmodium vivax malaria: Based on the qualitative data, the expectation for the implementation of the Biosensor was that G6PD testing would allow patients with vivax malaria to safely access radical cure and reduce vivax burden (cmn2, po1,4, do1, hc7, cnmp1).